Skip to main content

Table 13 Relation between interval from symptom onset to treatment and onset of death or discharge

From: Risk factors affecting outcome of rhino-orbital-cerebral mucormycosis in COVID-19 patients

 

Interval from symptom onset to treatment

r

p-value

Onset of death or discharge (days)

0.153

0.396

  1. P-value > 0.05, nonsignificant; P-value < 0.05, significant; P-value < 0.01, highly significant. Spearman correlation coefficient